Shawn Patrick O’Brien

Shawn Patrick O’Brien has more than 35 years of global pharmaceutical industry experience building successful enterprises. He is the founding partner of Key BioPharma Partners providing advice to life science companies and capital providers. Previously, he was the Chairman and CEO of Genomind, a personalised mental health platform company and President and CEO of Cipher Pharmaceuticals, Inc., a specialty pharmaceutical company with a portfolio of commercial stage dermatology products. He was also President and CEO of three private biotechs including AltheRx Pharmaceuticals, Profectus BioSciences Inc. and Solstice Neurosciences. Mr O’Brien spent 17 years with AstraZeneca where he held multiple senior leadership positions in Canada and the US including Vice President of Commercial Operations for Emerging Brands, Vice President and Therapy Area Leader, Respiratory and Inflammation and Commercial and Development Group Director for the Oncology Therapeutic area. Mr O’Brien began his career at the Upjohn Company of Canada (part of Pfizer).

Mr O’Brien is the Non-executive Chairman of SFA Therapeutics and Alto Pharma. He is a board member and Co-Chair of the Hubert J.P. Schoemaker Classic (golf charity fundraiser) and an advisory board member of Greater Philadelphia Life Sciences Congress. He was a 9-year Board member of the Crozer Keystone Hospital System, a former board member of Cyrano, LLC and Melanovus LLC.

Mr O’Brien holds a Bachelor of Science in Microbiology and Immunology from the University of Western Ontario.